Catalyst Wire Dossier Catalyst Wire Dossier

Fosinopril Sodium/Hydrochlorothiazide 20/12.5 mg tablets

fosinopril sodium/hydrochlorothiazide · Ranbaxy Laboratories Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Fosinopril Sodium/Hydrochlorothiazide 20/12.5 mg tablets, covering 2008-10-23 to 2008-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions [NA]

See pricing